Viral Matters focuses on all aspects of Direct Acting Antivirals (DAA) and Antiretrovirals in development and on the market.
Pages
▼
Thursday, August 9, 2012
'Viral Matters' HCV Drug Development discussion group on LinkedIn...
"Viral Matters" also has a home on LinkedIn as well, in the form of an HCV Drug Development discussion group. If you're a LinkedIn member, you can join the discussion here.
No comments:
Post a Comment